Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History ETON

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics ETON

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Eton Pharmaceuticals Inc

ETON
Current price
15.56 USD -0.16 USD (-1.02%)
Last closed 15.80 USD
ISIN US29772L1089
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 387 512 864 USD
Yield for 12 month +353.64 %
1Y
3Y
5Y
10Y
15Y
ETON
21.11.2021 - 28.11.2021

Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-400 for treating adrenal insufficiency; ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois. Address: 21925 W. Field Parkway, Deer Park, IL, United States, 60010-7278

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

29.67 USD

P/E Ratio

Dividend Yield

Financials ETON

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures ETON

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+39 011 000 USD

Last Year

+31 642 000 USD

Current Quarter

+17 282 000 USD

Last Quarter

+11 647 000 USD

Current Year

+23 411 000 USD

Last Year

+21 061 000 USD

Current Quarter

+9 861 000 USD

Last Quarter

+6 476 000 USD
EBITDA 3 000 USD
Operating Margin TTM -2.72 %
Price to Earnings
Return On Assets TTM -2.02 %
PEG Ratio
Return On Equity TTM -22.95 %
Wall Street Target Price 29.67 USD
Revenue TTM 48 327 000 USD
Book Value 0.91 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 116.90 %
Dividend Yield
Gross Profit TTM 28 265 000 USD
Earnings per share -0.18 USD
Diluted Eps TTM -0.18 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY -12.60 %
Profit Margin -9.48 %

Stock Valuation ETON

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 48.31
Enterprise Value Revenue 8.30
Price Sales TTM 8.02
Enterprise Value EBITDA 51.26
Price Book MRQ 15.88

Technical Indicators ETON

For 52 Weeks

3.25 USD 21.48 USD
50 Day MA 16.53 USD
Shares Short Prior Month 823 782
200 Day MA 13.21 USD
Short Ratio 2.38
Shares Short 1 120 282
Short Percent 4.39 %